Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cumberland Pharmaceuticals (CPIX) Leases (2019 - 2025)

Cumberland Pharmaceuticals' Leases history spans 7 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Leases rose 35.08% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $8.3 million, up 35.08%, while the annual FY2025 figure was $8.3 million, 35.08% up from the prior year.
  • Leases for Q4 2025 was $8.3 million at Cumberland Pharmaceuticals, up from $7.6 million in the prior quarter.
  • Across five years, Leases topped out at $8.3 million in Q4 2025 and bottomed at $219850.0 in Q3 2022.
  • The 5-year median for Leases is $6.2 million (2024), against an average of $4.5 million.
  • The largest annual shift saw Leases tumbled 82.85% in 2022 before it soared 2952.61% in 2023.
  • A 5-year view of Leases shows it stood at $1.0 million in 2021, then skyrocketed by 409.51% to $5.2 million in 2022, then increased by 28.61% to $6.7 million in 2023, then dropped by 7.96% to $6.2 million in 2024, then surged by 35.08% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Leases are $8.3 million (Q4 2025), $7.6 million (Q3 2025), and $7.1 million (Q2 2025).